Portland, OR -- (SBWIRE) -- 09/06/2017 -- Allied Market Research recently published a report on Europe In vitro fertilization market for the forecast period of 2014 to 2022. The market was valued at $3,054 million in 2015 and will increase to $4,447 million by 2022 with a CAGR of 5.4% in the forecast period. The report gives a brief description of the market, key benefits, coverage and limitations, and various research methodology used to formulate this study.
Europe IVF market report gives a descriptive analysis of market definition and scope, overview, market dynamics including drivers, restraints, and opportunities. It also includes the segregation of the Europe IVF market by country, cycle type, and end user.
Early buyers will receive 20% customization on this report
Factors such as delayed pregnancies in women and supportive regulations have been identified as the drivers for this market. Restraints such as inadequate reimbursement policies and ethical considerations can cause the market to slacken.
The Germany embryo transfer market analysis includes the market overview, market by cycle type, by end users and market dynamics including drivers and restraints. The market drivers identified are subsiding IVF treatments and delayed marriage and parenthood decisions. The restraints identified are strict government regulations and sparse availability in treatment cycles for IVF. This segment also contains regulatory issues and insurance reimbursement scenario. The key hospitals profiled are Heidelberg University Hospital, Klinikum Stuttgart, DRK Kliniken Berlin, and University Medical Center Freiburg.
The France embryo transfer market analysis contains market overview, market by cycle type, by end users and market dynamics including drivers and restraints. Factors such as same gender adoption of IVF babies and low rate of fertility are the major drivers. Stringent government regulations are a major restraint for the IVF market of France. The key clinics profiled are Clinique de la Muette, Hopital des metallurgists, hopital cochin.
Get PDF of this Report @ https://www.alliedmarketresearch.com/request-sample/1823
The UK embryo transfer market analysis contains an in-depth analysis of the market by cycle type and end user which includes clinics, surgical centers, and clinical research institutes. Drivers identified are the commercialization of three-parent IVF processes and supportive regulations. Ethical considerations can be a major drawback for the UK market. The clinics profiled are Lister Fertility Clinic, The Bridge Center, and Chelsea and Westminister Hospital.
Italy's embryo transfer market is analyzed based on the end user and cycle type, market dynamics, government regulations and key players. Growing medical tourism has been driving the market to growth and ban on surrogacy will slacken the market. The leading clinics and hospitals profiled are ARC-STER srl, RAPRUI and Center for Reproductive Medicine-Napoli.
The report contains Spain's embryo transfer market that is segmented on the basis of cycle type, end user, and market dynamics such as drivers and restraints. The increase in a number of foreign patients is a major driver and low awareness about IVF technology is a major drawback. Key hospitals profiled are IVF Spain and Clnica EUGIN Barcelona.
Denmark's embryo transfer market contains market division on the basis of cycle type, end user, and market dynamics such as drivers and restraints. Drivers identified are high disposable income and advances in IVF technology. Inadequate reimbursement policies can cause a drawback in the market. Key hospitals profiled are Copenhagen Fertility Center, Storkklinik v/Nina stork, vitanova, trianglen fertility clinic, NordicaDenmark Copenhagen.
The embryo transfer market of Russia contains a detailed analysis of the market-based on the end user and cycle type, market dynamics, government regulations and key players. Rising popularity of fertility tourism is a driving force while Inadequate reimbursement policies can cause a major restraint. The key hospitals profiled are AVA-Peter Clinic, MD Medical Group, and IVF Russia.
The major companies profiled in the study are Thermo Fisher Scientific Inc, DRK Kliniken Berlin, Sun Pharmaceutical Industries Ltd, Cadila Healthcare Ltd (Zydus Cadila Group), and LG life sciences.
The extensively analyzed study will facilitate the key players and investors grasp the lucrative investment pockets. The quantitative insights will help the market leaders understand the government regulations and look into the strategic moves of their competitors. This extensive study will be beneficial to investors looking to invest in the IVF service market in Europe.